Misguided Canadian Opioid-Prescribing Guidelines
Did Purdue Influence the Voting?
[From www.cbc.ca] The rules from Health Canada were clear when it awarded the half-million-dollar grant to McMaster's Michael G. DeGroote National Pain Centre in 2015: No one with any ties to big pharma could be allowed to vote on the final draft of the guidelines, which were intended to help doctors make difficult decisions about opioid use for chronic non-cancer pain.
As the hand-picked experts sat around the table arguing about when doctors should prescribe the dangerous pills, everyone in the room assumed everyone else in the room was free of industry ties. But the truth was revealed earlier this month, when the guidelines were finally published.
One of the members of the voting committee had ties to drug companies that sell opioids, including Purdue Pharma (Canada), which manufactured OxyContin, one of the most notorious prescription opioid drugs.
Nearly half of the pain specialists on the broader expert advisory committee (six of its 13 members) also disclosed ties to drug companies that make opioid pills.